Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 2/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.41 |
| ▸ | MEN1 | O00255 | 2/20 | 0.41 |
| ▸ | TSHR | P16473 | 8/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
| ▸ | CYP4F2 | P78329 | 2/20 | 0.36 |
| ▸ | CYP4A11 | Q02928 | 2/20 | 0.36 |
| ▸ | TP53 | P04637 | 2/20 | 0.35 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.35 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1506942 | 1.00 | THRB (0.52) | THRBALDH1A1KMT2AMEN1TSHR | |
| SCHEMBL1170691 | 0.93 | THRB (0.47) | THRBALDH1A1KMT2AMEN1TSHR | |
| SCHEMBL28963874 | 0.88 | MEN1 (0.48) | THRBALDH1A1KMT2AMEN1TSHR | |
| SCHEMBL11678089 | 0.88 | THRB (0.44) | THRBALDH1A1KMT2ATSHRMAPT | |
| SCHEMBL6897725 | 0.87 | THRB (0.46) | THRBALDH1A1KMT2AMEN1TSHR | |
| SCHEMBL27734344 | 0.87 | THRB (0.46) | THRBALDH1A1KMT2AMEN1TSHR | |
| SCHEMBL28416144 | 0.86 | MEN1 (0.46) | THRBALDH1A1KMT2AMEN1TSHR | |
| SCHEMBL130079 | 0.86 | THRB (0.68) | THRBALDH1A1TSHRMAPTHSD17B10 | |
| SCHEMBL28423063 | 0.86 | MEN1 (0.46) | THRBALDH1A1KMT2AMEN1TSHR | |
| SCHEMBL27630872 | 0.86 | MEN1 (0.46) | THRBALDH1A1KMT2AMEN1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 378 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025085828-A1 | SYSTEM AND METHOD FOR CONTROLLED POLYMER DEPOLYMERIZATION | Intropic Materials Corporation (US) | 2025-04-24 | — | — | WO | claimed |
| US-20250129391-A1 | SYSTEM AND METHOD FOR CONTROLLED POLYMER DEPOLYMERIZATION | Intropic Materials Corporation (US) | 2025-04-24 | — | — | US | claimed |
| US-9777160-B2 | Copper-containing metal pigments with a metal oxide layer and a plastic layer, method for the production thereof, coating agent and coated object | ECKART GMBH (DE) | 2017-10-03 | — | — | US | claimed |
| CN-102012535-B | Polarizing plate and photocurable adhesive for forming polarizing plate | TOYO INK MFG CO | 2014-08-13 | — | — | CN | claimed |
| US-20140050768-A1 | Copper-Containing Metal Pigments with a Metal Oxide Layer and a Plastic Layer, Method for the Production Thereof, Coating Agent and Coated Object | ECKART GMBH (DE) | 2014-02-20 | — | — | US | claimed |
| US-7211625-B2 | Thermoplastic resin composition and elastomer composition | KANEKA CORPORATION (JP) | 2007-05-01 | — | — | US | claimed |
| US-20040106732-A1 | Thermoplastic resin composition and elastomer composition | KANEKA CORPORATION (JP) | 2004-06-03 | — | — | US | claimed |
| EP-0222059-B1 | IMPROVED RADIATION-HARDENABLE DILUENTS | HENKEL CORPORATION (a Delaware corp.) (US) | 1992-07-08 | — | — | EP | claimed |
| EP-0222059-A2 | Improved radiation-hardenable diluents | HENKEL CORPORATION (a Delaware corp.) (US) | 1987-05-20 | — | — | EP | claimed |
| US-20260049184-A1 | CURABLE COMPOSITION AND INK FOR INK-JET PRINTING | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2026-02-19 | — | — | US | disclosed |
| EP-3660111-B1 | INK COMPOSITION, METHOD FOR PRODUCING SAME, AND IMAGE FORMATION METHOD | FUJIFILM CORP (JP) | 2026-02-18 | — | — | EP | disclosed |
| EP-4089147-B1 | CURABLE COMPOSITION AND INK FOR INK-JET PRINTING | SHINETSU CHEMICAL CO (JP) | 2026-02-04 | — | — | EP | disclosed |
| US-12502864-B2 | Optical body, optical film adhesive body, and method for manufacturing optical body | DEXERIALS CORPORATION (JP) | 2025-12-23 | — | — | US | disclosed |
| EP-4108983-B1 | OPTICAL BODY, METHOD FOR MANUFACTURING OPTICAL BODY, AND LIGHT-EMITTING APPARATUS | DEXERIALS CORP (JP) | 2025-12-03 | — | — | EP | disclosed |
| US-5455042-A | Ointment comprising a homogenous mixture of a polymer or copolymer of N-vinylacetamide, water and/or alcohols, and a pharmacologically active component | SHOWA DENKO KABUSHIKI KAISHA (JP) | 1995-10-03 | — | — | US | disclosed |
| US-5344655-A | Drug delivery | SHOWA DENKO K.K. (JP) | 1994-09-06 | — | — | US | disclosed |
| US-5254338-A | N-vinylacetamide polymer | SHOWA DENKO K.K. (JP) | 1993-10-19 | — | — | US | disclosed |
| EP-0446636-A2 | External application base or auxiliary agent and external application composition for human being or animal containing the same | SHOWA DENKO KABUSHIKI KAISHA (JP) | 1991-09-18 | — | — | EP | disclosed |
| EP-0360617-A2 | Dry toner, dry developer and process for forming images | Hitachi Chemical Co., Ltd. (JP) | 1990-03-28 | — | — | EP | disclosed |
| US-4686166-A | HIGH IMAGE DENSITY, ANTIFOGGING AGENT | HITACHI CHEMICAL CO. (JP) | 1987-08-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260049184-A1 | CURABLE COMPOSITION AND INK FOR INK-JET PRINTING | SEM1, COL1A1, HTR3D | THRB 2012/4885ALDH1A1 772/4885KMT2A 499/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.